Skip to content

Advance your Wound Care Practice with the FIT Case Report Challenge
Presented by Coloplast in collaboration with the Australian Wound & Skin Alliance (AWSA)

As proud advocates for clinical education and excellence in wound care, Coloplast is pleased to partner with AWSA to launch the FIT Case Report Challenge — a unique opportunity for healthcare professionals to showcase their clinical expertise, contribute to peer learning, and be recognised for excellence in wound care.

This initiative reflects Coloplast’s ongoing commitment to supporting healthcare professionals through evidence-based resources, clinical pathways, and opportunities for professional development. Preparing a case report not only contributes to the broader wound care community but also strengthens clinical reasoning and reflective practice.

Learn more about AWSA from Nikki Frescos and Terry Swanson  

     

Why Participate?
All submissions will be reviewed by an independent panel of wound care experts convened by AWSA. Top submissions will be recognised with awards designed to support further professional growth.

Hear from Nikki Frescos and Terry Swanson on the benefits of creating a case report  

   

First Place Award
• Valued up to AUD $6,000
• Includes attendance at the World Union of Wound Healing Societies Conference 2026 in Kuala Lumpur, Malaysia
• Opportunity to present at the AWSA Conference 2027, with mentoring and support from AWSA

Two Runner-Up Awards
• Valued up to AUD $1,500 each
• Contribution towards attending the AWSA Conference 2027

How to Enter – 3 Simple Steps

Hear from Nikki Frescos and Terry Swanson on how easy it is to participate

   

Step 1: Register from 1 December 2025
Visit Coloplast Professional or contact your Coloplast Territory Manager to request the FIT Case Report Pack, which includes:
• Case report template
• HCP consent forms
• FIT Case Report FAQs

Step 2: Prepare Your Case Report
• Find an appropriate patient with a chronic wound or at risk of forming a pressure injury
• Implement the relevant wound type specific pathway
• Treat with Biatain Silicone Fit

Step 3: Submit by 31 May 2026
Email your completed case report to woundAU@coloplast.com
Include the HCP consent form only (patient consent forms are not required for submission)


Key Dates
• Challenge Opens: 1 December 2025
• Submission Deadline: 31 May 2026 (11:59 PM AEDT)


Request Your FIT Case Report Pack
Australia: Complete the online form to download your pack
New Zealand: Contact your local Territory Manager directly

Included in the pack:
• Case Report Template
• Consent Forms
• FIT Case Report FAQs

FIT Case Report Challenge – Terms and Conditions

1. Eligibility Criteria
1.1 Entry is open to healthcare professionals (HCPs) aged 18 years and over who are residents of Australia or New Zealand.
1.2 Eligible participants must:
a. Be currently registered with the Australian Health Practitioner Regulation Agency (AHPRA) or the New Zealand equivalent (e.g. Medical Council, Nursing Council*, Podiatrists Board of New Zealand); and
b. Be able to provide evidence of employment in a clinical setting relevant to wound care.
(*Please note: nurses must be a registered nurse.)
1.3 Employees, agents, and contractors of Coloplast and the Australian Wound & Skin Alliance (AWSA), including their immediate family members, are not eligible to enter.
For the purposes of this clause, “immediate family members” include: spouse, ex-spouse, de facto partner, child or stepchild (biological or adopted), parent, step-parent, grandparent, step-grandparent, uncle, aunt, niece, nephew, sibling, step-sibling, or first cousin.
1.4 Coloplast and AWSA reserve the right to verify the eligibility of entries and entrants at any time. Entrants may be disqualified at the sole discretion of Coloplast or AWSA if found to be in breach of these Terms and Conditions.


2. Entry Instructions
2.1 Entries open on 1 December 2025 at 08:00 AEDT and close on 31 May 2026 at 23:59 AEDT.
2.2 Eligible HCPs may submit multiple case reports, provided each submission relates to a different patient.


3. Judging and Award Determination
3.1 The FIT Case Report Challenge is a skill-based competition. Chance plays no part in determining the winners.
3.2 All submissions will be evaluated by a panel of qualified wound care experts convened by AWSA.
3.3 Three finalists will be selected:
• One (1) First Place Winner – Author of the highest-ranked case report
• Two (2) Runner-Up Winners – Authors of the second and third highest-ranked case reports
3.4 The judging panel may also select reserve entries in ranked order, to be used in the event of disqualification, ineligibility, or unclaimed awards.
3.5 AWSA will notify the winners via email. If a winner does not respond within seven (7) calendar days of the second notification attempt, the prize will be forfeited and AWSA reserves the right to award the prize to the next eligible entrant.
3.6 The First Place Winner will collaborate with AWSA to arrange travel, registration, and accommodation in accordance with the award value.


4. Award Conditions
4.1 The First Place Winner will receive an award valued up to AUD $6,000, which will be used to attend the World Union of Wound Healing Societies Conference 2026 (Kuala Lumpur, Malaysia) and present at the AWSA Conference 2027, with mentoring support from AWSA.
4.2 Each Runner-Up Winner will receive an award valued up to AUD $1,500 to support attendance at the AWSA Conference 2027.
4.3 Awards are intended to cover costs associated with conference attendance, including registration fees, return economy airfares, accommodation, and transfers.
4.4 Awards are non-transferable, non-exchangeable, and cannot be redeemed for cash. Any unused portion of the award will be forfeited.
4.5 In the event the specified award is unavailable or impracticable to deliver, Coloplast reserves the right to substitute the award with one of equal value and/or comparable specification.


5. Intellectual Property
5.1 By submitting a case report to the FIT Case Report Challenge, entrants confirm that the content of their submission is original, does not infringe upon the intellectual property rights of any third party, and complies with all applicable privacy and confidentiality obligations.
5.2 Entrants retain ownership of the intellectual property in their submitted case reports. However, by entering the challenge, entrants grant Coloplast and AWSA a non-exclusive, royalty-free, worldwide, perpetual licence to use, reproduce, publish, adapt, and communicate the submitted case reports (in whole or in part) for the purposes of education, research, promotion, and professional development, including but not limited to publication in print and digital formats, presentations, and inclusion in clinical resources.
5.3 Any use of submitted case reports by Coloplast or AWSA will be appropriately attributed to the author(s), unless otherwise agreed.
5.4 Entrants must ensure that all patient information included in the case report is de-identified in accordance with applicable privacy laws and ethical standards. Coloplast and AWSA accept no responsibility for any breach of patient confidentiality resulting from failure to de-identify personal health information.


6. Disclaimer
6.1 Coloplast and AWSA make no representations or warranties regarding the accuracy, completeness, or suitability of any information, materials, or resources provided in connection with the FIT Case Report Challenge.
6.2 Participation in the challenge is voluntary and at the sole discretion of the entrant. Coloplast and AWSA shall not be liable for any direct, indirect, incidental, or consequential loss or damage arising from participation in the challenge, submission of case reports, or use of any award.
6.3 Coloplast and AWSA do not guarantee that participation in the challenge or receipt of an award will result in professional advancement, publication, or recognition beyond the scope of the challenge.
6.4 Entrants are responsible for ensuring that their submissions comply with all applicable laws, professional standards, and institutional policies, including those relating to patient privacy, consent, and clinical governance.